{"id":"23368034","title":"CANTEX CLOSES FINAL TRANCHE OF OVER SUBSCRIBED PRIVATE PLACEMENT WITH A FURTHER INVESTMENT BY CRESCAT CAPITAL LLC","author":null,"feed":"PRTGAM","feedName":"Newswire.ca","published":"Tue Jan 16, 2024","image":"N/A","content":"

KELOWNA, BC, Jan. 16, 2024 /CNW/ - Cantex Mine Development Corp. (TSXV: CD) (OTCQB: CTXDF) (the "Company") is pleased to announce the close of the final tranche of its financing.

","related":[{"id":"887088","title":"The Federal Reserve Is Raising Red Flags, and the Stock Market Isn't Listening","slug":"the-federal-reserve-is-raising-red-flags-and-the-stock-market-isn-t-listening","feedName":"Motley Fool","published":"8 minutes ago","categories":[]},{"id":"887075","title":"Savara (SVRA) Gets a Buy from LifeSci Capital","slug":"savara-svra-gets-a-buy-from-lifesci-capital","feedName":"Tipranks","published":"14 minutes ago","categories":[]},{"id":"887073","title":"Palvella Therapeutics (PVLA) Receives a Rating Update from a Top Analyst","slug":"palvella-therapeutics-pvla-receives-a-rating-update-from-a-top-analyst","feedName":"Tipranks","published":"14 minutes ago","categories":[]},{"id":"887071","title":"Spyre Therapeutics (SYRE) Receives a Rating Update from a Top Analyst","slug":"spyre-therapeutics-syre-receives-a-rating-update-from-a-top-analyst","feedName":"Tipranks","published":"14 minutes ago","categories":[]},{"id":"887069","title":"LifeSci Capital Sticks to Their Buy Rating for Abivax SA Sponsored ADR (ABVX)","slug":"lifesci-capital-sticks-to-their-buy-rating-for-abivax-sa-sponsored-adr-abvx","feedName":"Tipranks","published":"14 minutes ago","categories":[]},{"id":"887067","title":"Ibio (IBIO) Receives a Buy from LifeSci Capital","slug":"ibio-ibio-receives-a-buy-from-lifesci-capital","feedName":"Tipranks","published":"14 minutes ago","categories":[]},{"id":"887065","title":"LifeSci Capital Sticks to Its Buy Rating for Amylyx Pharmaceuticals Inc (AMLX)","slug":"lifesci-capital-sticks-to-its-buy-rating-for-amylyx-pharmaceuticals-inc-amlx","feedName":"Tipranks","published":"15 minutes ago","categories":[]},{"id":"887063","title":"Eupraxia Pharmaceuticals (EPRX) Receives a Rating Update from a Top Analyst","slug":"eupraxia-pharmaceuticals-eprx-receives-a-rating-update-from-a-top-analyst","feedName":"Tipranks","published":"15 minutes ago","categories":[]},{"id":"887061","title":"LifeSci Capital Keeps Their Buy Rating on Structure Therapeutics, Inc. Sponsored ADR (GPCR)","slug":"lifesci-capital-keeps-their-buy-rating-on-structure-therapeutics-inc-sponsored-adr-gpcr","feedName":"Tipranks","published":"15 minutes ago","categories":[]}],"sourceId":"newswireca-2024-1-16-cantex-closes-final-tranche-of-over-subscribed-private-placement-with-a-further-investment-by-crescat-capital-llc","media":"text","thumbnail":"N/A","canonicalUrl":"https://www.newswire.ca/news-releases/cantex-closes-final-tranche-of-over-subscribed-private-placement-with-a-further-investment-by-crescat-capital-llc-889204124.html","feedUrl":null,"slug":"cantex-closes-final-tranche-of-over-subscribed-private-placement-with-a-further-investment-by-crescat-capital-llc"}

Latest in

More

CANTEX CLOSES FINAL TRANCHE OF OVER SUBSCRIBED PRIVATE PLACEMENT WITH A FURTHER INVESTMENT BY CRESCAT CAPITAL LLC